1999
DOI: 10.1177/030006059902700505
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Evaluation of a Haemostatic and Anti-Adhesion Preparation Used to Prevent Post-Surgical Adhesion

Abstract: TachoComb® consists of equine collagen in a sponge-like form coated on one side with human fibrinogen and bovine thrombin. This product functions as a haemostatic and physical barrier to inhibit post-surgical adhesion. In this study, we investigated TachoComb® to control oozing in 16 patients who required haemostasis. Evaluation of post-surgical adhesion by second-look laparoscopy was performed at 3 months and 7 months after initial surgery. Observation via laparotomy during Caesarean section was also performe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
23
0

Year Published

2003
2003
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 29 publications
(24 citation statements)
references
References 2 publications
1
23
0
Order By: Relevance
“…10 This is unsupported by several studies using fibrinderived materials in animals [11][12][13][14][15][16][17][18][19][20][21][22] and humans. [23][24][25][26] One reason fibrin may be used to reduce rather than enhance adhesions is that once polymerization is complete, an adhesion barrier may form that cannot stick to other surfaces. The hemostatic and sealing properties of fibrin sealants, as well as their widespread availability, make them attractive candidates for use in adhesion prevention.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…10 This is unsupported by several studies using fibrinderived materials in animals [11][12][13][14][15][16][17][18][19][20][21][22] and humans. [23][24][25][26] One reason fibrin may be used to reduce rather than enhance adhesions is that once polymerization is complete, an adhesion barrier may form that cannot stick to other surfaces. The hemostatic and sealing properties of fibrin sealants, as well as their widespread availability, make them attractive candidates for use in adhesion prevention.…”
Section: Introductionmentioning
confidence: 99%
“…Given the clinical use [23][24][25][26] of fibrin preparations for adhesion prevention, the objective therefore was to determine the effect on adhesion development of the type, dose, and volume of antifibrinolytic agents (tranexamic acid, aprotinin) added to fibrin formulations.…”
Section: Introductionmentioning
confidence: 99%
“…In a study of TachoComb ® in patients undergoing gynaecological surgery, all but one of four patients evaluated by second-look laparoscopy (after 3 or 7 months) and all three patients evaluated by caesarean section (after 13 months, 3 years and 4 years) showed no sign of persistent TachoComb ® . 27 In addition, there was no evidence of de novo adhesion formation. 27 Such data demonstrate the natural degradation of the fleece and imply a longterm beneficial effect of TachoComb ® in preventing adhesion-induced infertility, although further long-term follow-up data are required.…”
Section: Discussionmentioning
confidence: 95%
“…27 In addition, there was no evidence of de novo adhesion formation. 27 Such data demonstrate the natural degradation of the fleece and imply a longterm beneficial effect of TachoComb ® in preventing adhesion-induced infertility, although further long-term follow-up data are required.…”
Section: Discussionmentioning
confidence: 95%
“…TachoComb ® continues to be applied in endoscopic (23), vascular, thyroid, lung, hepatic, urological and ENT surgery, gynaecology and obstetrics (1,2,6,15), as well as in macroscopic and histological experimental studies (3,11,19,20) and in neurosurgery, where it serves as a dural substitute (14,17).…”
Section: Introductionmentioning
confidence: 99%